<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33966637</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>09</Month>
        <Day>29</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>09</Month>
        <Day>29</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1423-0127</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>28</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>May</Month>
              <Day>09</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of biomedical science</Title>
          <ISOAbbreviation>J Biomed Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Notch-ing up knowledge on molecular mechanisms of skin fibrosis: focus on the multifaceted Notch signalling pathway.</ArticleTitle>
        <Pagination>
          <StartPage>36</StartPage>
          <MedlinePgn>36</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">36</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12929-021-00732-8</ELocationID>
        <Abstract>
          <AbstractText>Fibrosis can be defined as an excessive and deregulated deposition of extracellular matrix proteins, causing loss of physiological architecture and dysfunction of different tissues and organs. In the skin, fibrosis represents the hallmark of several acquired (e.g. systemic sclerosis and hypertrophic scars) and inherited (i.e. dystrophic epidermolysis bullosa) diseases. A complex series of interactions among a variety of cellular types and a wide range of molecular players drive the fibrogenic process, often in a context-dependent manner. However, the pathogenetic mechanisms leading to skin fibrosis are not completely elucidated. In this scenario, an increasing body of evidence has recently disclosed the involvement of Notch signalling cascade in fibrosis of the skin and other organs. Despite its apparent simplicity, Notch represents one of the most multifaceted, strictly regulated and intricate pathways with still unknown features both in health and disease conditions. Starting from the most recent advances in Notch activation and regulation, this review focuses on the pro-fibrotic function of Notch pathway in fibroproliferative skin disorders describing molecular networks, interplay with other pro-fibrotic molecules and pathways, including the transforming growth factor-β1, and therapeutic strategies under development.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Condorelli</LastName>
            <ForeName>Angelo Giuseppe</ForeName>
            <Initials>AG</Initials>
            <Identifier Source="ORCID">0000-0003-1502-5852</Identifier>
            <AffiliationInfo>
              <Affiliation>Genodermatosis Unit, Genetics and Rare Diseases Research Division, Bambino Gesù Children's Hospital, IRCCS, Piazza Sant' Onofrio 4, 00165, Rome, Italy. agiuseppe.condorelli@opbg.net.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>El Hachem</LastName>
            <ForeName>May</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Dermatology Unit and Genodermatosis Unit, Genetics and Rare Diseases Research Division, Bambino Gesù Children's Hospital, IRCCS, Piazza Sant' Onofrio 4, 00165, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zambruno</LastName>
            <ForeName>Giovanna</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Genodermatosis Unit, Genetics and Rare Diseases Research Division, Bambino Gesù Children's Hospital, IRCCS, Piazza Sant' Onofrio 4, 00165, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nystrom</LastName>
            <ForeName>Alexander</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Medical Faculty, Medical Center, University of Freiburg, Freiburg, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Candi</LastName>
            <ForeName>Eleonora</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Experimental Medicine, University of Rome "Tor Vergata", via Montpellier, 1, 00133, Rome, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>IDI-IRCCS, via Monti di Creta 104, 00167, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Castiglia</LastName>
            <ForeName>Daniele</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Molecular and Cell Biology, IDI-IRCCS, via Monti di Creta 104, 00167, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>05</Month>
          <Day>09</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Biomed Sci</MedlineTA>
        <NlmUniqueID>9421567</NlmUniqueID>
        <ISSNLinking>1021-7770</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051880">Receptors, Notch</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D017439" MajorTopicYN="N">Cicatrix, Hypertrophic</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005355" MajorTopicYN="N">Fibrosis</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051880" MajorTopicYN="N">Receptors, Notch</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012595" MajorTopicYN="N">Scleroderma, Systemic</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Dermal fibroblasts</Keyword>
        <Keyword MajorTopicYN="N">Epidermolysis bullosa</Keyword>
        <Keyword MajorTopicYN="N">Extracellular matrix</Keyword>
        <Keyword MajorTopicYN="N">Gamma-secretase inhibitor</Keyword>
        <Keyword MajorTopicYN="N">Hypertrophic scar</Keyword>
        <Keyword MajorTopicYN="N">JAG1</Keyword>
        <Keyword MajorTopicYN="N">Keloid</Keyword>
        <Keyword MajorTopicYN="N">NOTCH1</Keyword>
        <Keyword MajorTopicYN="N">Systemic sclerosis</Keyword>
        <Keyword MajorTopicYN="N">Transforming growth factor-β1</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33966637</ArticleId>
        <ArticleId IdType="pmc">PMC8106838</ArticleId>
        <ArticleId IdType="doi">10.1186/s12929-021-00732-8</ArticleId>
        <ArticleId IdType="pii">10.1186/s12929-021-00732-8</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Do NN, Eming SA. Skin fibrosis: models and mechanisms. Curr Res Transl Med. 2016;64(4):185–193. doi: 10.1016/j.retram.2016.06.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.retram.2016.06.003</ArticleId>
            <ArticleId IdType="pubmed">27939457</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Distler JHW, Gyorfi AH, Ramanujam M, Whitfield ML, Konigshoff M, Lafyatis R. Shared and distinct mechanisms of fibrosis. Nat Rev Rheumatol. 2019;15(12):705–730. doi: 10.1038/s41584-019-0322-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41584-019-0322-7</ArticleId>
            <ArticleId IdType="pubmed">31712723</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uitto J, Jimenez S. Fibrotic skin diseases. Clinical presentations, etiologic considerations, and treatment options. Arch Dermatol. 1990;126(5):661–664. doi: 10.1001/archderm.126.5.661.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archderm.126.5.661</ArticleId>
            <ArticleId IdType="pubmed">2185697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Canady J, Karrer S, Fleck M, Bosserhoff AK. Fibrosing connective tissue disorders of the skin: molecular similarities and distinctions. J Dermatol Sci. 2013;70(3):151–158. doi: 10.1016/j.jdermsci.2013.03.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jdermsci.2013.03.005</ArticleId>
            <ArticleId IdType="pubmed">23631956</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nystrom A, Bruckner-Tuderman L. Injury- and inflammation-driven skin fibrosis: the paradigm of epidermolysis bullosa. Matrix Biol. 2018;68–69:547–560. doi: 10.1016/j.matbio.2018.01.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.matbio.2018.01.016</ArticleId>
            <ArticleId IdType="pubmed">29391280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-beta: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12(6):325–338. doi: 10.1038/nrneph.2016.48.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrneph.2016.48</ArticleId>
            <ArticleId IdType="pubmed">27108839</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gyorfi AH, Matei AE, Distler JHW. Targeting TGF-beta signaling for the treatment of fibrosis. Matrix Biol. 2018;68–69:8–27. doi: 10.1016/j.matbio.2017.12.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.matbio.2017.12.016</ArticleId>
            <ArticleId IdType="pubmed">29355590</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mehal WZ, Iredale J, Friedman SL. Scraping fibrosis: expressway to the core of fibrosis. Nat Med. 2011;17(5):552–553. doi: 10.1038/nm0511-552.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm0511-552</ArticleId>
            <ArticleId IdType="pmc">PMC3219752</ArticleId>
            <ArticleId IdType="pubmed">21546973</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ogawa R. Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis. Int J Mol Sci. 2017 doi: 10.3390/ijms18030606.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms18030606</ArticleId>
            <ArticleId IdType="pmc">PMC5372622</ArticleId>
            <ArticleId IdType="pubmed">28287424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jeljeli M, Riccio LGC, Doridot L, Chene C, Nicco C, Chouzenoux S, Deletang Q, Allanore Y, Kavian N, Batteux F. Trained immunity modulates inflammation-induced fibrosis. Nat Commun. 2019;10(1):5670. doi: 10.1038/s41467-019-13636-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-019-13636-x</ArticleId>
            <ArticleId IdType="pmc">PMC6906311</ArticleId>
            <ArticleId IdType="pubmed">31827093</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Siebel C, Lendahl U. Notch signaling in development, tissue homeostasis, and disease. Physiol Rev. 2017;97(4):1235–1294. doi: 10.1152/physrev.00005.2017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/physrev.00005.2017</ArticleId>
            <ArticleId IdType="pubmed">28794168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, Smith SD, Sklar J. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell. 1991;66(4):649–661. doi: 10.1016/0092-8674(91)90111-b.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0092-8674(91)90111-b</ArticleId>
            <ArticleId IdType="pubmed">1831692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferrando AA. The role of NOTCH1 signaling in T-ALL. Hematol Am Soc Hematol Educ Program. 2009 doi: 10.1182/asheducation-2009.1.353.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/asheducation-2009.1.353</ArticleId>
            <ArticleId IdType="pmc">PMC2847371</ArticleId>
            <ArticleId IdType="pubmed">20008221</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ranganathan P, Weaver KL, Capobianco AJ. Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer. 2011;11(5):338–351. doi: 10.1038/nrc3035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrc3035</ArticleId>
            <ArticleId IdType="pubmed">21508972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Masek J, Andersson ER. The developmental biology of genetic Notch disorders. Development. 2017;144(10):1743–1763. doi: 10.1242/dev.148007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.148007</ArticleId>
            <ArticleId IdType="pubmed">28512196</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mitchell E, Gilbert M, Loomes KM. Alagille syndrome. Clin Liver Dis. 2018;22(4):625–641. doi: 10.1016/j.cld.2018.06.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cld.2018.06.001</ArticleId>
            <ArticleId IdType="pubmed">30266153</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu B, Phan SH. Notch in fibrosis and as a target of anti-fibrotic therapy. Pharmacol Res. 2016;108:57–64. doi: 10.1016/j.phrs.2016.04.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.phrs.2016.04.010</ArticleId>
            <ArticleId IdType="pmc">PMC5074914</ArticleId>
            <ArticleId IdType="pubmed">27107790</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meloty-Kapella L, Shergill B, Kuon J, Botvinick E, Weinmaster G. Notch ligand endocytosis generates mechanical pulling force dependent on dynamin, epsins, and actin. Dev Cell. 2012;22(6):1299–1312. doi: 10.1016/j.devcel.2012.04.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.devcel.2012.04.005</ArticleId>
            <ArticleId IdType="pmc">PMC3400432</ArticleId>
            <ArticleId IdType="pubmed">22658936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gordon WR, Zimmerman B, He L, Miles LJ, Huang J, Tiyanont K, McArthur DG, Aster JC, Perrimon N, Loparo JJ, Blacklow SC. Mechanical allostery: evidence for a force requirement in the proteolytic activation of Notch. Dev Cell. 2015;33(6):729–736. doi: 10.1016/j.devcel.2015.05.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.devcel.2015.05.004</ArticleId>
            <ArticleId IdType="pmc">PMC4481192</ArticleId>
            <ArticleId IdType="pubmed">26051539</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schroeter EH, Kisslinger JA, Kopan R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature. 1998;393(6683):382–386. doi: 10.1038/30756.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/30756</ArticleId>
            <ArticleId IdType="pubmed">9620803</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mumm JS, Schroeter EH, Saxena MT, Griesemer A, Tian X, Pan DJ, Ray WJ, Kopan R. A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol Cell. 2000;5(2):197–206. doi: 10.1016/s1097-2765(00)80416-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s1097-2765(00)80416-5</ArticleId>
            <ArticleId IdType="pubmed">10882062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rand MD, Grimm LM, Artavanis-Tsakonas S, Patriub V, Blacklow SC, Sklar J, Aster JC. Calcium depletion dissociates and activates heterodimeric notch receptors. Mol Cell Biol. 2000;20(5):1825–1835. doi: 10.1128/mcb.20.5.1825-1835.2000.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mcb.20.5.1825-1835.2000</ArticleId>
            <ArticleId IdType="pmc">PMC85363</ArticleId>
            <ArticleId IdType="pubmed">10669757</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yugawa T, Nishino K, Ohno S, Nakahara T, Fujita M, Goshima N, Umezawa A, Kiyono T. Noncanonical NOTCH signaling limits self-renewal of human epithelial and induced pluripotent stem cells through ROCK activation. Mol Cell Biol. 2013;33(22):4434–4447. doi: 10.1128/MCB.00577-13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MCB.00577-13</ArticleId>
            <ArticleId IdType="pmc">PMC3838179</ArticleId>
            <ArticleId IdType="pubmed">24019071</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weinmaster G, Fischer JA. Notch ligand ubiquitylation: what is it good for? Dev Cell. 2011;21(1):134–144. doi: 10.1016/j.devcel.2011.06.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.devcel.2011.06.006</ArticleId>
            <ArticleId IdType="pmc">PMC3156059</ArticleId>
            <ArticleId IdType="pubmed">21763614</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cohen M, Georgiou M, Stevenson NL, Miodownik M, Baum B. Dynamic filopodia transmit intermittent Delta-Notch signaling to drive pattern refinement during lateral inhibition. Dev Cell. 2010;19(1):78–89. doi: 10.1016/j.devcel.2010.06.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.devcel.2010.06.006</ArticleId>
            <ArticleId IdType="pubmed">20643352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng D, Yan X, Qiu G, Zhang J, Wang H, Feng T, Tian Y, Xu H, Wang M, He W, Wu P, Widelitz RB, Chuong CM, Yue Z. Contraction of basal filopodia controls periodic feather branching via Notch and FGF signaling. Nat Commun. 2018;9(1):1345. doi: 10.1038/s41467-018-03801-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-018-03801-z</ArticleId>
            <ArticleId IdType="pmc">PMC5890251</ArticleId>
            <ArticleId IdType="pubmed">29632339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hunter GL, He L, Perrimon N, Charras G, Giniger E, Baum B. A role for actomyosin contractility in Notch signaling. BMC Biol. 2019;17(1):12. doi: 10.1186/s12915-019-0625-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12915-019-0625-9</ArticleId>
            <ArticleId IdType="pmc">PMC6369551</ArticleId>
            <ArticleId IdType="pubmed">30744634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Q, Lu Q. Plasma membrane-derived extracellular microvesicles mediate non-canonical intercellular NOTCH signaling. Nat Commun. 2017;8(1):709. doi: 10.1038/s41467-017-00767-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-017-00767-2</ArticleId>
            <ArticleId IdType="pmc">PMC5617834</ArticleId>
            <ArticleId IdType="pubmed">28955033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun Z, Wang L, Zhou Y, Dong L, Ma W, Lv L, Zhang J, Wang X. Glioblastoma stem cell-derived exosomes enhance stemness and tumorigenicity of glioma cells by transferring Notch1 protein. Cell Mol Neurobiol. 2020;40(5):767–784. doi: 10.1007/s10571-019-00771-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10571-019-00771-8</ArticleId>
            <ArticleId IdType="pubmed">31853695</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Borggrefe T, Oswald F. The Notch signaling pathway: transcriptional regulation at Notch target genes. Cell Mol Life Sci. 2009;66(10):1631–1646. doi: 10.1007/s00018-009-8668-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00018-009-8668-7</ArticleId>
            <ArticleId IdType="pubmed">19165418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang H, Zang C, Liu XS, Aster JC. The role of Notch receptors in transcriptional regulation. J Cell Physiol. 2015;230(5):982–988. doi: 10.1002/jcp.24872.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcp.24872</ArticleId>
            <ArticleId IdType="pmc">PMC4442318</ArticleId>
            <ArticleId IdType="pubmed">25418913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gomez-Lamarca MJ, Falo-Sanjuan J, Stojnic R, Abdul Rehman S, Muresan L, Jones ML, Pillidge Z, Cerda-Moya G, Yuan Z, Baloul S, Valenti P, Bystricky K, Payre F, O'Holleran K, Kovall R, Bray SJ. Activation of the Notch signaling pathway in vivo elicits changes in CSL nuclear dynamics. Dev Cell. 2018;44(5):611–23 e7. doi: 10.1016/j.devcel.2018.01.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.devcel.2018.01.020</ArticleId>
            <ArticleId IdType="pmc">PMC5855320</ArticleId>
            <ArticleId IdType="pubmed">29478922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kageyama R, Ohtsuka T, Kobayashi T. The Hes gene family: repressors and oscillators that orchestrate embryogenesis. Development. 2007;134(7):1243–1251. doi: 10.1242/dev.000786.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.000786</ArticleId>
            <ArticleId IdType="pubmed">17329370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Antfolk D, Antila C, Kemppainen K, Landor SK, Sahlgren C. Decoding the PTM-switchboard of Notch. Biochim Biophys Acta Mol Cell Res. 2019;1866(12):118507. doi: 10.1016/j.bbamcr.2019.07.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbamcr.2019.07.002</ArticleId>
            <ArticleId IdType="pmc">PMC7116576</ArticleId>
            <ArticleId IdType="pubmed">31301363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chitnis A, Bally-Cuif L. The Notch meeting: an odyssey from structure to function. Development. 2016;143(7):1229. doi: 10.1242/dev.136846.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.136846</ArticleId>
            <ArticleId IdType="pmc">PMC6514386</ArticleId>
            <ArticleId IdType="pubmed">26952976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lopez-Arribillaga E, Rodilla V, Colomer C, Vert A, Shelton A, Cheng JH, Yan B, Gonzalez-Perez A, Junttila MR, Iglesias M, Torres F, Albanell J, Villanueva A, Bigas A, Siebel CW, Espinosa L. Manic fringe deficiency imposes Jagged1 addiction to intestinal tumor cells. Nat Commun. 2018;9(1):2992. doi: 10.1038/s41467-018-05385-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-018-05385-0</ArticleId>
            <ArticleId IdType="pmc">PMC6068201</ArticleId>
            <ArticleId IdType="pubmed">30065304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu G, Lyapina S, Das I, Li J, Gurney M, Pauley A, Chui I, Deshaies RJ, Kitajewski J. SEL-10 is an inhibitor of notch signaling that targets notch for ubiquitin-mediated protein degradation. Mol Cell Biol. 2001;21(21):7403–7415. doi: 10.1128/MCB.21.21.7403-7415.2001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MCB.21.21.7403-7415.2001</ArticleId>
            <ArticleId IdType="pmc">PMC99913</ArticleId>
            <ArticleId IdType="pubmed">11585921</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morrugares R, Correa-Saez A, Moreno R, Garrido-Rodriguez M, Munoz E, de la Vega L, Calzado MA. Phosphorylation-dependent regulation of the NOTCH1 intracellular domain by dual-specificity tyrosine-regulated kinase 2. Cell Mol Life Sci. 2020;77(13):2621–2639. doi: 10.1007/s00018-019-03309-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00018-019-03309-9</ArticleId>
            <ArticleId IdType="pmc">PMC7320039</ArticleId>
            <ArticleId IdType="pubmed">31605148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fryer CJ, White JB, Jones KA. Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. Mol Cell. 2004;16(4):509–520. doi: 10.1016/j.molcel.2004.10.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molcel.2004.10.014</ArticleId>
            <ArticleId IdType="pubmed">15546612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hashimi ST, Fulcher JA, Chang MH, Gov L, Wang S, Lee B. MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation. Blood. 2009;114(2):404–414. doi: 10.1182/blood-2008-09-179150.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2008-09-179150</ArticleId>
            <ArticleId IdType="pmc">PMC2927176</ArticleId>
            <ArticleId IdType="pubmed">19398721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Y, Guessous F, Zhang Y, Dipierro C, Kefas B, Johnson E, Marcinkiewicz L, Jiang J, Yang Y, Schmittgen TD, Lopes B, Schiff D, Purow B, Abounader R. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res. 2009;69(19):7569–7576. doi: 10.1158/0008-5472.CAN-09-0529.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-09-0529</ArticleId>
            <ArticleId IdType="pmc">PMC2756313</ArticleId>
            <ArticleId IdType="pubmed">19773441</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang M, Li CJ, Sun X, Guo Q, Xiao Y, Su T, Tu ML, Peng H, Lu Q, Liu Q, He HB, Jiang TJ, Lei MX, Wan M, Cao X, Luo XH. MiR-497 approximately 195 cluster regulates angiogenesis during coupling with osteogenesis by maintaining endothelial Notch and HIF-1alpha activity. Nat Commun. 2017;8:16003. doi: 10.1038/ncomms16003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncomms16003</ArticleId>
            <ArticleId IdType="pmc">PMC5504303</ArticleId>
            <ArticleId IdType="pubmed">28685750</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Genz B, Coleman MA, Irvine KM, Kutasovic JR, Miranda M, Gratte FD, Tirnitz-Parker JEE, Olynyk JK, Calvopina DA, Weis A, Cloonan N, Robinson H, Hill MM, Al-Ejeh F, Ramm GA. Overexpression of miRNA-25-3p inhibits Notch1 signaling and TGF-beta-induced collagen expression in hepatic stellate cells. Sci Rep. 2019;9(1):8541. doi: 10.1038/s41598-019-44865-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-019-44865-1</ArticleId>
            <ArticleId IdType="pmc">PMC6561916</ArticleId>
            <ArticleId IdType="pubmed">31189969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao S, Xiao X, Sun S, Li D, Wang W, Fu Y, Fan F. MicroRNA-30d/JAG1 axis modulates pulmonary fibrosis through Notch signaling pathway. Pathol Res Pract. 2018;214(9):1315–1323. doi: 10.1016/j.prp.2018.02.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.prp.2018.02.014</ArticleId>
            <ArticleId IdType="pubmed">30029934</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Condorelli AG, Logli E, Cianfarani F, Teson M, Diociaiuti A, El Hachem M, Zambruno G, Castiglia D, Odorisio T. MicroRNA-145-5p regulates fibrotic features of recessive dystrophic epidermolysis bullosa skin fibroblasts. Br J Dermatol. 2019;181(5):1017–1027. doi: 10.1111/bjd.17840.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bjd.17840</ArticleId>
            <ArticleId IdType="pubmed">30816994</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li J, Dong S, Ye M, Peng G, Luo J, Wang C, Wang J, Zhao Q, Chang Y, Wang H. MicroRNA-489-3p represses hepatic stellate cells activation by negatively regulating the JAG1/Notch3 signaling pathway. Dig Dis Sci. 2020 doi: 10.1007/s10620-020-06174-w.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10620-020-06174-w</ArticleId>
            <ArticleId IdType="pubmed">32144602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wasson CW, Abignano G, Hermes H, Malaab M, Ross RL, Jimenez SA, Chang HY, Feghali-Bostwick CA, Del Galdo F. Long non-coding RNA HOTAIR drives EZH2-dependent myofibroblast activation in systemic sclerosis through miRNA 34a-dependent activation of NOTCH. Ann Rheum Dis. 2020;79(4):507–517. doi: 10.1136/annrheumdis-2019-216542.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/annrheumdis-2019-216542</ArticleId>
            <ArticleId IdType="pmc">PMC7147169</ArticleId>
            <ArticleId IdType="pubmed">32041748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boucher JM, Peterson SM, Urs S, Zhang C, Liaw L. The miR-143/145 cluster is a novel transcriptional target of Jagged-1/Notch signaling in vascular smooth muscle cells. J Biol Chem. 2011;286(32):28312–28321. doi: 10.1074/jbc.M111.221945.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M111.221945</ArticleId>
            <ArticleId IdType="pmc">PMC3151075</ArticleId>
            <ArticleId IdType="pubmed">21685392</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chandiran K, Lawlor R, Pannuti A, Perez GG, Srinivasan J, Golde TE, Miele L, Osborne BA, Minter LM. Notch1 primes CD4 T cells for T helper type I differentiation through its early effects on miR-29. Mol Immunol. 2018;99:191–198. doi: 10.1016/j.molimm.2018.05.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molimm.2018.05.002</ArticleId>
            <ArticleId IdType="pmc">PMC6281167</ArticleId>
            <ArticleId IdType="pubmed">29807327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172(3):393–407. doi: 10.1016/j.cell.2018.01.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2018.01.011</ArticleId>
            <ArticleId IdType="pmc">PMC5978744</ArticleId>
            <ArticleId IdType="pubmed">29373828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wan Y, Yang ZQ. LncRNA NEAT1 affects inflammatory response by targeting miR-129-5p and regulating Notch signaling pathway in epilepsy. Cell Cycle. 2020;19(4):419–431. doi: 10.1080/15384101.2020.1711578.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/15384101.2020.1711578</ArticleId>
            <ArticleId IdType="pmc">PMC7100884</ArticleId>
            <ArticleId IdType="pubmed">31948324</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rani N, Nowakowski TJ, Zhou H, Godshalk SE, Lisi V, Kriegstein AR, Kosik KS. A primate lncRNA mediates Notch signaling during neuronal development by sequestering miRNA. Neuron. 2016;90(6):1174–1188. doi: 10.1016/j.neuron.2016.05.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2016.05.005</ArticleId>
            <ArticleId IdType="pmc">PMC4911262</ArticleId>
            <ArticleId IdType="pubmed">27263970</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trimarchi T, Bilal E, Ntziachristos P, Fabbri G, Dalla-Favera R, Tsirigos A, Aifantis I. Genome-wide mapping and characterization of Notch-regulated long noncoding RNAs in acute leukemia. Cell. 2014;158(3):593–606. doi: 10.1016/j.cell.2014.05.049.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2014.05.049</ArticleId>
            <ArticleId IdType="pmc">PMC4131209</ArticleId>
            <ArticleId IdType="pubmed">25083870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Z, Li G, Qiu H, Yang J, Bu X, Zhu S, Zheng J, Dang C, Wang W, Chu D. The novel Notch-induced long noncoding RNA LUNAR1 determines the proliferation and prognosis of colorectal cancer. Sci Rep. 2019;9(1):19915. doi: 10.1038/s41598-019-56536-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-019-56536-2</ArticleId>
            <ArticleId IdType="pmc">PMC6934546</ArticleId>
            <ArticleId IdType="pubmed">31882986</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reicher A, Fosselteder J, Kwong LN, Pichler M. Crosstalk between the Notch signaling pathway and long non-coding RNAs. Cancer Lett. 2018;420:91–96. doi: 10.1016/j.canlet.2018.01.070.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.canlet.2018.01.070</ArticleId>
            <ArticleId IdType="pubmed">29409809</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ghafouri-Fard S, Glassy MC, Abak A, Hussen BM, Niazi V, Taheri M. The interaction between miRNAs/lncRNAs and Notch pathway in human disorders. Biomed Pharmacother. 2021;138:111496. doi: 10.1016/j.biopha.2021.111496.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biopha.2021.111496</ArticleId>
            <ArticleId IdType="pubmed">33743335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tang Y, Boucher JM, Liaw L. Histone deacetylase activity selectively regulates notch-mediated smooth muscle differentiation in human vascular cells. J Am Heart Assoc. 2012;1(3):e000901. doi: 10.1161/JAHA.112.000901.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/JAHA.112.000901</ArticleId>
            <ArticleId IdType="pmc">PMC3487326</ArticleId>
            <ArticleId IdType="pubmed">23130137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang J, Wang CD, Zhang N, Tong WX, Zhang YF, Shan SZ, Zhang XL, Li QF. Mechanical stimulation orchestrates the osteogenic differentiation of human bone marrow stromal cells by regulating HDAC1. Cell Death Dis. 2016;7:e2221. doi: 10.1038/cddis.2016.112.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cddis.2016.112</ArticleId>
            <ArticleId IdType="pmc">PMC4917651</ArticleId>
            <ArticleId IdType="pubmed">27171263</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tung CW, Hsu YC, Cai CJ, Shih YH, Wang CJ, Chang PJ, Lin CL. Trichostatin A ameliorates renal tubulointerstitial fibrosis through modulation of the JNK-dependent Notch-2 signaling pathway. Sci Rep. 2017;7(1):14495. doi: 10.1038/s41598-017-15162-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-017-15162-6</ArticleId>
            <ArticleId IdType="pmc">PMC5670251</ArticleId>
            <ArticleId IdType="pubmed">29101337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pinazza M, Ghisi M, Minuzzo S, Agnusdei V, Fossati G, Ciminale V, Pezze L, Ciribilli Y, Pilotto G, Venturoli C, Amadori A, Indraccolo S. Histone deacetylase 6 controls Notch3 trafficking and degradation in T-cell acute lymphoblastic leukemia cells. Oncogene. 2018;37(28):3839–3851. doi: 10.1038/s41388-018-0234-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41388-018-0234-z</ArticleId>
            <ArticleId IdType="pmc">PMC6041259</ArticleId>
            <ArticleId IdType="pubmed">29643474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang C, Chen Y, Sun B, Wang L, Yang Y, Ma D, Lv J, Heng J, Ding Y, Xue Y, Lu X, Xiao W, Yang YG, Liu F. m(6)A modulates haematopoietic stem and progenitor cell specification. Nature. 2017;549(7671):273–276. doi: 10.1038/nature23883.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature23883</ArticleId>
            <ArticleId IdType="pubmed">28869969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Visvanathan A, Patil V, Abdulla S, Hoheisel JD, Somasundaram K. N(6)-methyladenosine landscape of glioma stem-like cells: METTL3 is essential for the expression of actively transcribed genes and sustenance of the oncogenic signaling. Genes (Basel). 2019 doi: 10.3390/genes10020141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/genes10020141</ArticleId>
            <ArticleId IdType="pmc">PMC6410051</ArticleId>
            <ArticleId IdType="pubmed">30781903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maity A, Das B. N6-methyladenosine modification in mRNA: machinery, function and implications for health and diseases. FEBS J. 2016;283(9):1607–1630. doi: 10.1111/febs.13614.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/febs.13614</ArticleId>
            <ArticleId IdType="pubmed">26645578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Warda AS, Kretschmer J, Hackert P, Lenz C, Urlaub H, Hobartner C, Sloan KE, Bohnsack MT. Human METTL16 is a N(6)-methyladenosine (m(6)A) methyltransferase that targets pre-mRNAs and various non-coding RNAs. EMBO Rep. 2017;18(11):2004–2014. doi: 10.15252/embr.201744940.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.15252/embr.201744940</ArticleId>
            <ArticleId IdType="pmc">PMC5666602</ArticleId>
            <ArticleId IdType="pubmed">29051200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mathiyalagan P, Adamiak M, Mayourian J, Sassi Y, Liang Y, Agarwal N, Jha D, Zhang S, Kohlbrenner E, Chepurko E, Chen J, Trivieri MG, Singh R, Bouchareb R, Fish K, Ishikawa K, Lebeche D, Hajjar RJ, Sahoo S. FTO-Dependent N(6)-methyladenosine regulates cardiac function during remodeling and repair. Circulation. 2019;139(4):518–532. doi: 10.1161/CIRCULATIONAHA.118.033794.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.033794</ArticleId>
            <ArticleId IdType="pmc">PMC6400591</ArticleId>
            <ArticleId IdType="pubmed">29997116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang H, Weng H, Chen J. m(6)A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer. Cancer Cell. 2020;37(3):270–288. doi: 10.1016/j.ccell.2020.02.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccell.2020.02.004</ArticleId>
            <ArticleId IdType="pmc">PMC7141420</ArticleId>
            <ArticleId IdType="pubmed">32183948</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schaefer L. Decoding fibrosis: mechanisms and translational aspects. Matrix Biol. 2018;68–69:1–7. doi: 10.1016/j.matbio.2018.04.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.matbio.2018.04.009</ArticleId>
            <ArticleId IdType="pubmed">29679639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Landen NX, Li D, Stahle M. Transition from inflammation to proliferation: a critical step during wound healing. Cell Mol Life Sci. 2016;73(20):3861–3885. doi: 10.1007/s00018-016-2268-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00018-016-2268-0</ArticleId>
            <ArticleId IdType="pmc">PMC5021733</ArticleId>
            <ArticleId IdType="pubmed">27180275</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cianfarani F, Zambruno G, Castiglia D, Odorisio T. Pathomechanisms of altered wound healing in recessive dystrophic epidermolysis bullosa. Am J Pathol. 2017;187(7):1445–1453. doi: 10.1016/j.ajpath.2017.03.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajpath.2017.03.003</ArticleId>
            <ArticleId IdType="pubmed">28460207</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pakshir P, Hinz B. The big five in fibrosis: macrophages, myofibroblasts, matrix, mechanics, and miscommunication. Matrix Biol. 2018;68–69:81–93. doi: 10.1016/j.matbio.2018.01.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.matbio.2018.01.019</ArticleId>
            <ArticleId IdType="pubmed">29408013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hinz B, McCulloch CA, Coelho NM. Mechanical regulation of myofibroblast phenoconversion and collagen contraction. Exp Cell Res. 2019;379(1):119–128. doi: 10.1016/j.yexcr.2019.03.027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yexcr.2019.03.027</ArticleId>
            <ArticleId IdType="pubmed">30910400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang S, Park J, Qiu C, Chung KW, Li SY, Sirin Y, Han SH, Taylor V, Zimber-Strobl U, Susztak K. Jagged1/Notch2 controls kidney fibrosis via Tfam-mediated metabolic reprogramming. PLoS Biol. 2018;16(9):e2005233. doi: 10.1371/journal.pbio.2005233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pbio.2005233</ArticleId>
            <ArticleId IdType="pmc">PMC6161902</ArticleId>
            <ArticleId IdType="pubmed">30226866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu C, Kim K, Wang X, Bartolome A, Salomao M, Dongiovanni P, Meroni M, Graham MJ, Yates KP, Diehl AM, Schwabe RF, Tabas I, Valenti L, Lavine JE, Pajvani UB. Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis. Sci Transl Med. 2018 doi: 10.1126/scitranslmed.aat0344.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/scitranslmed.aat0344</ArticleId>
            <ArticleId IdType="pmc">PMC6822168</ArticleId>
            <ArticleId IdType="pubmed">30463916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang YC, Chen Q, Luo JM, Nie J, Meng QH, Shuai W, Xie H, Xia JM, Wang H. Notch1 promotes the pericyte-myofibroblast transition in idiopathic pulmonary fibrosis through the PDGFR/ROCK1 signal pathway. Exp Mol Med. 2019;51(3):1–11. doi: 10.1038/s12276-019-0228-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s12276-019-0228-0</ArticleId>
            <ArticleId IdType="pmc">PMC6430797</ArticleId>
            <ArticleId IdType="pubmed">30902967</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cereseto A, Tsai S. Jagged2 induces cell cycling in confluent fibroblasts susceptible to density-dependent inhibition of cell division. J Cell Physiol. 2000;185(3):425–431. doi: 10.1002/1097-4652(200012)185:3&lt;425::AID-JCP13&gt;3.0.CO;2-U.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/1097-4652(200012)185:3&lt;425::AID-JCP13&gt;3.0.CO;2-U</ArticleId>
            <ArticleId IdType="pubmed">11056013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dees C, Tomcik M, Zerr P, Akhmetshina A, Horn A, Palumbo K, Beyer C, Zwerina J, Distler O, Schett G, Distler JH. Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis. Ann Rheum Dis. 2011;70(7):1304–1310. doi: 10.1136/ard.2010.134742.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/ard.2010.134742</ArticleId>
            <ArticleId IdType="pubmed">21450749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doi H, Iso T, Sato H, Yamazaki M, Matsui H, Tanaka T, Manabe I, Arai M, Nagai R, Kurabayashi M. Jagged1-selective notch signaling induces smooth muscle differentiation via a RBP-Jkappa-dependent pathway. J Biol Chem. 2006;281(39):28555–28564. doi: 10.1074/jbc.M602749200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M602749200</ArticleId>
            <ArticleId IdType="pubmed">16867989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhattacharyya A, Lin S, Sandig M, Mequanint K. Regulation of vascular smooth muscle cell phenotype in three-dimensional coculture system by Jagged1-selective Notch3 signaling. Tissue Eng Part A. 2014;20(7–8):1175–1187. doi: 10.1089/ten.TEA.2013.0268.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/ten.TEA.2013.0268</ArticleId>
            <ArticleId IdType="pmc">PMC3993058</ArticleId>
            <ArticleId IdType="pubmed">24138322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klose R, Prinz A, Tetzlaff F, Weis EM, Moll I, Rodriguez-Vita J, Oka C, Korff T, Fischer A. Loss of the serine protease HTRA1 impairs smooth muscle cells maturation. Sci Rep. 2019;9(1):18224. doi: 10.1038/s41598-019-54807-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-019-54807-6</ArticleId>
            <ArticleId IdType="pmc">PMC6890777</ArticleId>
            <ArticleId IdType="pubmed">31796853</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Noseda M, McLean G, Niessen K, Chang L, Pollet I, Montpetit R, Shahidi R, Dorovini-Zis K, Li L, Beckstead B, Durand RE, Hoodless PA, Karsan A. Notch activation results in phenotypic and functional changes consistent with endothelial-to-mesenchymal transformation. Circ Res. 2004;94(7):910–917. doi: 10.1161/01.RES.0000124300.76171.C9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.RES.0000124300.76171.C9</ArticleId>
            <ArticleId IdType="pubmed">14988227</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Noseda M, Fu Y, Niessen K, Wong F, Chang L, McLean G, Karsan A. Smooth muscle alpha-actin is a direct target of Notch/CSL. Circ Res. 2006;98(12):1468–1470. doi: 10.1161/01.RES.0000229683.81357.26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.RES.0000229683.81357.26</ArticleId>
            <ArticleId IdType="pubmed">16741155</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tang Y, Urs S, Liaw L. Hairy-related transcription factors inhibit Notch-induced smooth muscle alpha-actin expression by interfering with Notch intracellular domain/CBF-1 complex interaction with the CBF-1-binding site. Circ Res. 2008;102(6):661–668. doi: 10.1161/CIRCRESAHA.107.165134.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCRESAHA.107.165134</ArticleId>
            <ArticleId IdType="pmc">PMC2662732</ArticleId>
            <ArticleId IdType="pubmed">18239137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zavadil J, Cermak L, Soto-Nieves N, Bottinger EP. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J. 2004;23(5):1155–1165. doi: 10.1038/sj.emboj.7600069.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.emboj.7600069</ArticleId>
            <ArticleId IdType="pmc">PMC380966</ArticleId>
            <ArticleId IdType="pubmed">14976548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Radtke F, Fasnacht N, Macdonald HR. Notch signaling in the immune system. Immunity. 2010;32(1):14–27. doi: 10.1016/j.immuni.2010.01.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2010.01.004</ArticleId>
            <ArticleId IdType="pubmed">20152168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wei K, Korsunsky I, Marshall JL, Gao A, Watts GFM, Major T, Croft AP, Watts J, Blazar PE, Lange JK, Thornhill TS, Filer A, Raza K, Donlin LT, Accelerating Medicines Partnership Rheumatoid A, Systemic Lupus Erythematosus C, Siebel CW, Buckley CD, Raychaudhuri S, Brenner MB. Notch signalling drives synovial fibroblast identity and arthritis pathology. Nature. 2020;582(7811):259–64. 10.1038/s41586-020-2222-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7841716</ArticleId>
            <ArticleId IdType="pubmed">32499639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao X, Psarianos P, Ghoraie LS, Yip K, Goldstein D, Gilbert R, Witterick I, Pang H, Hussain A, Lee JH, Williams J, Bratman SV, Ailles L, Haibe-Kains B, Liu FF. Metabolic regulation of dermal fibroblasts contributes to skin extracellular matrix homeostasis and fibrosis. Nat Metab. 2019;1(1):147–157. doi: 10.1038/s42255-018-0008-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s42255-018-0008-5</ArticleId>
            <ArticleId IdType="pubmed">32694814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Castro Bras LE, Frangogiannis NG. Extracellular matrix-derived peptides in tissue remodeling and fibrosis. Matrix Biol. 2020;91–92:176–187. doi: 10.1016/j.matbio.2020.04.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.matbio.2020.04.006</ArticleId>
            <ArticleId IdType="pmc">PMC7434701</ArticleId>
            <ArticleId IdType="pubmed">32438055</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DeLeon-Pennell KY, Barker TH, Lindsey ML. Fibroblasts: the arbiters of extracellular matrix remodeling. Matrix Biol. 2020;91–92:1–7. doi: 10.1016/j.matbio.2020.05.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.matbio.2020.05.006</ArticleId>
            <ArticleId IdType="pmc">PMC7434687</ArticleId>
            <ArticleId IdType="pubmed">32504772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. J Cell Sci. 2010;123(Pt 24):4195–4200. doi: 10.1242/jcs.023820.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/jcs.023820</ArticleId>
            <ArticleId IdType="pmc">PMC2995612</ArticleId>
            <ArticleId IdType="pubmed">21123617</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nystrom A, Bruckner-Tuderman L. Matrix molecules and skin biology. Semin Cell Dev Biol. 2019;89:136–146. doi: 10.1016/j.semcdb.2018.07.025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semcdb.2018.07.025</ArticleId>
            <ArticleId IdType="pubmed">30076963</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iozzo RV, Gubbiotti MA. Extracellular matrix: the driving force of mammalian diseases. Matrix Biol. 2018;71–72:1–9. doi: 10.1016/j.matbio.2018.03.023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.matbio.2018.03.023</ArticleId>
            <ArticleId IdType="pmc">PMC6146050</ArticleId>
            <ArticleId IdType="pubmed">29625183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nystrom A, Bernasconi R, Bornert O. Therapies for genetic extracellular matrix diseases of the skin. Matrix Biol. 2018;71–72:330–347. doi: 10.1016/j.matbio.2017.12.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.matbio.2017.12.010</ArticleId>
            <ArticleId IdType="pubmed">29274938</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhattacharjee O, Ayyangar U, Kurbet AS, Ashok D, Raghavan S. Unraveling the ECM-immune cell crosstalk in skin diseases. Front Cell Dev Biol. 2019;7:68. doi: 10.3389/fcell.2019.00068.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcell.2019.00068</ArticleId>
            <ArticleId IdType="pmc">PMC6514232</ArticleId>
            <ArticleId IdType="pubmed">31134198</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herrera J, Henke CA, Bitterman PB. Extracellular matrix as a driver of progressive fibrosis. J Clin Invest. 2018;128(1):45–53. doi: 10.1172/JCI93557.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI93557</ArticleId>
            <ArticleId IdType="pmc">PMC5749528</ArticleId>
            <ArticleId IdType="pubmed">29293088</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ricard-Blum S, Baffet G, Theret N. Molecular and tissue alterations of collagens in fibrosis. Matrix Biol. 2018;68–69:122–149. doi: 10.1016/j.matbio.2018.02.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.matbio.2018.02.004</ArticleId>
            <ArticleId IdType="pubmed">29458139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Henke E, Nandigama R, Ergun S. Extracellular matrix in the tumor microenvironment and its impact on cancer therapy. Front Mol Biosci. 2019;6:160. doi: 10.3389/fmolb.2019.00160.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmolb.2019.00160</ArticleId>
            <ArticleId IdType="pmc">PMC7025524</ArticleId>
            <ArticleId IdType="pubmed">32118030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hinz B. The extracellular matrix and transforming growth factor-beta1: tale of a strained relationship. Matrix Biol. 2015;47:54–65. doi: 10.1016/j.matbio.2015.05.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.matbio.2015.05.006</ArticleId>
            <ArticleId IdType="pubmed">25960420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schulz JN, Plomann M, Sengle G, Gullberg D, Krieg T, Eckes B. New developments on skin fibrosis—essential signals emanating from the extracellular matrix for the control of myofibroblasts. Matrix Biol. 2018;68–69:522–532. doi: 10.1016/j.matbio.2018.01.025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.matbio.2018.01.025</ArticleId>
            <ArticleId IdType="pubmed">29408278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schnieder J, Mamazhakypov A, Birnhuber A, Wilhelm J, Kwapiszewska G, Ruppert C, Markart P, Wujak L, Rubio K, Barreto G, Schaefer L, Wygrecka M. Loss of LRP1 promotes acquisition of contractile-myofibroblast phenotype and release of active TGF-beta1 from ECM stores. Matrix Biol. 2020;88:69–88. doi: 10.1016/j.matbio.2019.12.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.matbio.2019.12.001</ArticleId>
            <ArticleId IdType="pubmed">31841706</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kechagia JZ, Ivaska J, Roca-Cusachs P. Integrins as biomechanical sensors of the microenvironment. Nat Rev Mol Cell Biol. 2019;20(8):457–473. doi: 10.1038/s41580-019-0134-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41580-019-0134-2</ArticleId>
            <ArticleId IdType="pubmed">31182865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>LaFoya B, Munroe JA, Mia MM, Detweiler MA, Crow JJ, Wood T, Roth S, Sharma B, Albig AR. Notch: a multi-functional integrating system of microenvironmental signals. Dev Biol. 2016;418(2):227–241. doi: 10.1016/j.ydbio.2016.08.023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ydbio.2016.08.023</ArticleId>
            <ArticleId IdType="pmc">PMC5144577</ArticleId>
            <ArticleId IdType="pubmed">27565024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lemaire R, Korn JH, Shipley JM, Lafyatis R. Increased expression of type I collagen induced by microfibril-associated glycoprotein 2: novel mechanistic insights into the molecular basis of dermal fibrosis in scleroderma. Arthritis Rheum. 2005;52(6):1812–1823. doi: 10.1002/art.21059.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.21059</ArticleId>
            <ArticleId IdType="pubmed">15934076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nehring LC, Miyamoto A, Hein PW, Weinmaster G, Shipley JM. The extracellular matrix protein MAGP-2 interacts with Jagged1 and induces its shedding from the cell surface. J Biol Chem. 2005;280(21):20349–20355. doi: 10.1074/jbc.M500273200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M500273200</ArticleId>
            <ArticleId IdType="pubmed">15788413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miyamoto A, Lau R, Hein PW, Shipley JM, Weinmaster G. Microfibrillar proteins MAGP-1 and MAGP-2 induce Notch1 extracellular domain dissociation and receptor activation. J Biol Chem. 2006;281(15):10089–10097. doi: 10.1074/jbc.M600298200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M600298200</ArticleId>
            <ArticleId IdType="pubmed">16492672</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deford P, Brown K, Richards RL, King A, Newburn K, Westover K, Albig AR. MAGP2 controls Notch via interactions with RGD binding integrins: identification of a novel ECM-integrin-Notch signaling axis. Exp Cell Res. 2016;341(1):84–91. doi: 10.1016/j.yexcr.2016.01.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yexcr.2016.01.011</ArticleId>
            <ArticleId IdType="pmc">PMC4817345</ArticleId>
            <ArticleId IdType="pubmed">26808411</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>LaFoya B, Munroe JA, Pu X, Albig AR. Src kinase phosphorylates Notch1 to inhibit MAML binding. Sci Rep. 2018;8(1):15515. doi: 10.1038/s41598-018-33920-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-018-33920-y</ArticleId>
            <ArticleId IdType="pmc">PMC6195628</ArticleId>
            <ArticleId IdType="pubmed">30341382</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tanabe H, Takayama I, Nishiyama T, Shimazaki M, Kii I, Li M, Amizuka N, Katsube K, Kudo A. Periostin associates with Notch1 precursor to maintain Notch1 expression under a stress condition in mouse cells. PLoS ONE. 2010;5(8):e12234. doi: 10.1371/journal.pone.0012234.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0012234</ArticleId>
            <ArticleId IdType="pmc">PMC2923609</ArticleId>
            <ArticleId IdType="pubmed">20805882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang X, Meng H, Wang MM. Collagen represses canonical Notch signaling and binds to Notch ectodomain. Int J Biochem Cell Biol. 2013;45(7):1274–1280. doi: 10.1016/j.biocel.2013.03.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biocel.2013.03.020</ArticleId>
            <ArticleId IdType="pmc">PMC3683383</ArticleId>
            <ArticleId IdType="pubmed">23579095</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Estrach S, Cailleteau L, Franco CA, Gerhardt H, Stefani C, Lemichez E, Gagnoux-Palacios L, Meneguzzi G, Mettouchi A. Laminin-binding integrins induce Dll4 expression and Notch signaling in endothelial cells. Circ Res. 2011;109(2):172–182. doi: 10.1161/CIRCRESAHA.111.240622.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCRESAHA.111.240622</ArticleId>
            <ArticleId IdType="pubmed">21474814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>David CJ, Massague J. Contextual determinants of TGFbeta action in development, immunity and cancer. Nat Rev Mol Cell Biol. 2018;19(7):419–435. doi: 10.1038/s41580-018-0007-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41580-018-0007-0</ArticleId>
            <ArticleId IdType="pmc">PMC7457231</ArticleId>
            <ArticleId IdType="pubmed">29643418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Massague J. How cells read TGF-beta signals. Nat Rev Mol Cell Biol. 2000;1(3):169–178. doi: 10.1038/35043051.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/35043051</ArticleId>
            <ArticleId IdType="pubmed">11252892</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003;113(6):685–700. doi: 10.1016/s0092-8674(03)00432-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0092-8674(03)00432-x</ArticleId>
            <ArticleId IdType="pubmed">12809600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frangogiannis N. Transforming growth factor-beta in tissue fibrosis. J Exp Med. 2020;217(3):e20190103. doi: 10.1084/jem.20190103.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.20190103</ArticleId>
            <ArticleId IdType="pmc">PMC7062524</ArticleId>
            <ArticleId IdType="pubmed">32997468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lodyga M, Hinz B. TGF-beta1—a truly transforming growth factor in fibrosis and immunity. Semin Cell Dev Biol. 2020;101:123–139. doi: 10.1016/j.semcdb.2019.12.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semcdb.2019.12.010</ArticleId>
            <ArticleId IdType="pubmed">31879265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zavadil J, Bitzer M, Liang D, Yang YC, Massimi A, Kneitz S, Piek E, Bottinger EP. Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc Natl Acad Sci U S A. 2001;98(12):6686–6691. doi: 10.1073/pnas.111614398.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.111614398</ArticleId>
            <ArticleId IdType="pmc">PMC34413</ArticleId>
            <ArticleId IdType="pubmed">11390996</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kluppel M, Wrana JL. Turning it up a Notch: cross-talk between TGF beta and Notch signaling. BioEssays. 2005;27(2):115–118. doi: 10.1002/bies.20187.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/bies.20187</ArticleId>
            <ArticleId IdType="pubmed">15666349</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grieskamp T, Rudat C, Ludtke TH, Norden J, Kispert A. Notch signaling regulates smooth muscle differentiation of epicardium-derived cells. Circ Res. 2011;108(7):813–823. doi: 10.1161/CIRCRESAHA.110.228809.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCRESAHA.110.228809</ArticleId>
            <ArticleId IdType="pubmed">21252157</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohnuki H, Jiang K, Wang D, Salvucci O, Kwak H, Sanchez-Martin D, Maric D, Tosato G. Tumor-infiltrating myeloid cells activate Dll4/Notch/TGF-beta signaling to drive malignant progression. Cancer Res. 2014;74(7):2038–2049. doi: 10.1158/0008-5472.CAN-13-3118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-13-3118</ArticleId>
            <ArticleId IdType="pmc">PMC3985086</ArticleId>
            <ArticleId IdType="pubmed">24520074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Borggrefe T, Lauth M, Zwijsen A, Huylebroeck D, Oswald F, Giaimo BD. The Notch intracellular domain integrates signals from Wnt, Hedgehog, TGFbeta/BMP and hypoxia pathways. Biochim Biophys Acta. 2016;1863(2):303–313. doi: 10.1016/j.bbamcr.2015.11.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbamcr.2015.11.020</ArticleId>
            <ArticleId IdType="pubmed">26592459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blokzijl A, Dahlqvist C, Reissmann E, Falk A, Moliner A, Lendahl U, Ibanez CF. Cross-talk between the Notch and TGF-beta signaling pathways mediated by interaction of the Notch intracellular domain with Smad3. J Cell Biol. 2003;163(4):723–728. doi: 10.1083/jcb.200305112.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.200305112</ArticleId>
            <ArticleId IdType="pmc">PMC2173673</ArticleId>
            <ArticleId IdType="pubmed">14638857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao Z, Zhang J, Peng X, Dong Y, Jia L, Li H, Du J. The Notch gamma-secretase inhibitor ameliorates kidney fibrosis via inhibition of TGF-beta/Smad2/3 signaling pathway activation. Int J Biochem Cell Biol. 2014;55:65–71. doi: 10.1016/j.biocel.2014.08.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biocel.2014.08.009</ArticleId>
            <ArticleId IdType="pubmed">25150830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Y, Huang G, Mo B, Wang C. Artesunate ameliorates lung fibrosis via inhibiting the Notch signaling pathway. Exp Ther Med. 2017;14(1):561–566. doi: 10.3892/etm.2017.4573.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/etm.2017.4573</ArticleId>
            <ArticleId IdType="pmc">PMC5488411</ArticleId>
            <ArticleId IdType="pubmed">28672967</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Shen RW, Han B, Li Z, Xiong L, Zhang FY, Cong BB, Zhang B. Notch signaling mediated by TGF-beta/Smad pathway in concanavalin A-induced liver fibrosis in rats. World J Gastroenterol. 2017;23(13):2330–2336. doi: 10.3748/wjg.v23.i13.2330.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3748/wjg.v23.i13.2330</ArticleId>
            <ArticleId IdType="pmc">PMC5385399</ArticleId>
            <ArticleId IdType="pubmed">28428712</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fan J, Shen W, Lee SR, Mathai AE, Zhang R, Xu G, Gillies MC. Targeting the Notch and TGF-beta signaling pathways to prevent retinal fibrosis in vitro and in vivo. Theranostics. 2020;10(18):7956–7973. doi: 10.7150/thno.45192.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7150/thno.45192</ArticleId>
            <ArticleId IdType="pmc">PMC7381727</ArticleId>
            <ArticleId IdType="pubmed">32724452</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tang Y, Urs S, Boucher J, Bernaiche T, Venkatesh D, Spicer DB, Vary CP, Liaw L. Notch and transforming growth factor-beta (TGFbeta) signaling pathways cooperatively regulate vascular smooth muscle cell differentiation. J Biol Chem. 2010;285(23):17556–17563. doi: 10.1074/jbc.M109.076414.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M109.076414</ArticleId>
            <ArticleId IdType="pmc">PMC2878520</ArticleId>
            <ArticleId IdType="pubmed">20368328</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kurpinski K, Lam H, Chu J, Wang A, Kim A, Tsay E, Agrawal S, Schaffer DV, Li S. Transforming growth factor-beta and notch signaling mediate stem cell differentiation into smooth muscle cells. Stem Cells. 2010;28(4):734–742. doi: 10.1002/stem.319.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/stem.319</ArticleId>
            <ArticleId IdType="pubmed">20146266</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aoyagi-Ikeda K, Maeno T, Matsui H, Ueno M, Hara K, Aoki Y, Aoki F, Shimizu T, Doi H, Kawai-Kowase K, Iso T, Suga T, Arai M, Kurabayashi M. Notch induces myofibroblast differentiation of alveolar epithelial cells via transforming growth factor-{beta}-Smad3 pathway. Am J Respir Cell Mol Biol. 2011;45(1):136–144. doi: 10.1165/rcmb.2010-0140OC.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1165/rcmb.2010-0140OC</ArticleId>
            <ArticleId IdType="pubmed">21749980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manokawinchoke J, Sumrejkanchanakij P, Pavasant P, Osathanon T. Notch signaling participates in TGF-beta-induced SOST expression under intermittent compressive stress. J Cell Physiol. 2017;232(8):2221–2230. doi: 10.1002/jcp.25740.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcp.25740</ArticleId>
            <ArticleId IdType="pubmed">27966788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piersma B, de Rond S, Werker PM, Boo S, Hinz B, van Beuge MM, Bank RA. YAP1 is a driver of myofibroblast differentiation in normal and diseased fibroblasts. Am J Pathol. 2015;185(12):3326–3337. doi: 10.1016/j.ajpath.2015.08.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajpath.2015.08.011</ArticleId>
            <ArticleId IdType="pubmed">26458763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Totaro A, Castellan M, Di Biagio D, Piccolo S. Crosstalk between YAP/TAZ and Notch signaling. Trends Cell Biol. 2018;28(7):560–573. doi: 10.1016/j.tcb.2018.03.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tcb.2018.03.001</ArticleId>
            <ArticleId IdType="pmc">PMC6992418</ArticleId>
            <ArticleId IdType="pubmed">29665979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burgy O, Konigshoff M. The WNT signaling pathways in wound healing and fibrosis. Matrix Biol. 2018;68–69:67–80. doi: 10.1016/j.matbio.2018.03.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.matbio.2018.03.017</ArticleId>
            <ArticleId IdType="pubmed">29572156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Foltz DR, Santiago MC, Berechid BE, Nye JS. Glycogen synthase kinase-3beta modulates notch signaling and stability. Curr Biol. 2002;12(12):1006–1011. doi: 10.1016/s0960-9822(02)00888-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0960-9822(02)00888-6</ArticleId>
            <ArticleId IdType="pubmed">12123574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Espinosa L, Ingles-Esteve J, Aguilera C, Bigas A. Phosphorylation by glycogen synthase kinase-3 beta down-regulates Notch activity, a link for Notch and Wnt pathways. J Biol Chem. 2003;278(34):32227–32235. doi: 10.1074/jbc.M304001200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M304001200</ArticleId>
            <ArticleId IdType="pubmed">12794074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jin YH, Kim H, Ki H, Yang I, Yang N, Lee KY, Kim N, Park HS, Kim K. Beta-catenin modulates the level and transcriptional activity of Notch1/NICD through its direct interaction. Biochim Biophys Acta. 2009;1793(2):290–299. doi: 10.1016/j.bbamcr.2008.10.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbamcr.2008.10.002</ArticleId>
            <ArticleId IdType="pubmed">19000719</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peignon G, Durand A, Cacheux W, Ayrault O, Terris B, Laurent-Puig P, Shroyer NF, Van Seuningen I, Honjo T, Perret C, Romagnolo B. Complex interplay between beta-catenin signalling and Notch effectors in intestinal tumorigenesis. Gut. 2011;60(2):166–176. doi: 10.1136/gut.2009.204719.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gut.2009.204719</ArticleId>
            <ArticleId IdType="pmc">PMC3022366</ArticleId>
            <ArticleId IdType="pubmed">21205878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Collu GM, Hidalgo-Sastre A, Brennan K. Wnt-Notch signalling crosstalk in development and disease. Cell Mol Life Sci. 2014;71(18):3553–3567. doi: 10.1007/s00018-014-1644-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00018-014-1644-x</ArticleId>
            <ArticleId IdType="pubmed">24942883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zheng L, Conner SD. Glycogen synthase kinase 3beta inhibition enhances Notch1 recycling. Mol Biol Cell. 2018;29(4):389–395. doi: 10.1091/mbc.E17-07-0474.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1091/mbc.E17-07-0474</ArticleId>
            <ArticleId IdType="pmc">PMC6014177</ArticleId>
            <ArticleId IdType="pubmed">29237816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edeling M, Ragi G, Huang S, Pavenstadt H, Susztak K. Developmental signalling pathways in renal fibrosis: the roles of Notch, Wnt and Hedgehog. Nat Rev Nephrol. 2016;12(7):426–439. doi: 10.1038/nrneph.2016.54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrneph.2016.54</ArticleId>
            <ArticleId IdType="pmc">PMC5529143</ArticleId>
            <ArticleId IdType="pubmed">27140856</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thelu J, Rossio P, Favier B. Notch signalling is linked to epidermal cell differentiation level in basal cell carcinoma, psoriasis and wound healing. BMC Dermatol. 2002;2:7. doi: 10.1186/1471-5945-2-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-5945-2-7</ArticleId>
            <ArticleId IdType="pmc">PMC111189</ArticleId>
            <ArticleId IdType="pubmed">11978185</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blanpain C, Lowry WE, Pasolli HA, Fuchs E. Canonical notch signaling functions as a commitment switch in the epidermal lineage. Genes Dev. 2006;20(21):3022–3035. doi: 10.1101/gad.1477606.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.1477606</ArticleId>
            <ArticleId IdType="pmc">PMC1620020</ArticleId>
            <ArticleId IdType="pubmed">17079689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Okuyama R, Tagami H, Aiba S. Notch signaling: its role in epidermal homeostasis and in the pathogenesis of skin diseases. J Dermatol Sci. 2008;49(3):187–194. doi: 10.1016/j.jdermsci.2007.05.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jdermsci.2007.05.017</ArticleId>
            <ArticleId IdType="pubmed">17624739</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nowell C, Radtke F. Cutaneous Notch signaling in health and disease. Cold Spring Harb Perspect Med. 2013;3(12):a017772. doi: 10.1101/cshperspect.a017772.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/cshperspect.a017772</ArticleId>
            <ArticleId IdType="pmc">PMC3839599</ArticleId>
            <ArticleId IdType="pubmed">24296353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lowell S, Jones P, Le Roux I, Dunne J, Watt FM. Stimulation of human epidermal differentiation by delta-notch signalling at the boundaries of stem-cell clusters. Curr Biol. 2000;10(9):491–500. doi: 10.1016/s0960-9822(00)00451-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0960-9822(00)00451-6</ArticleId>
            <ArticleId IdType="pubmed">10801437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nickoloff BJ, Qin JZ, Chaturvedi V, Denning MF, Bonish B, Miele L. Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-kappaB and PPARgamma. Cell Death Differ. 2002;9(8):842–855. doi: 10.1038/sj.cdd.4401036.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.cdd.4401036</ArticleId>
            <ArticleId IdType="pubmed">12107827</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Negri VA, Logtenberg MEW, Renz LM, Oules B, Walko G, Watt FM. Delta-like 1-mediated cis-inhibition of Jagged1/2 signalling inhibits differentiation of human epidermal cells in culture. Sci Rep. 2019;9(1):10825. doi: 10.1038/s41598-019-47232-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-019-47232-2</ArticleId>
            <ArticleId IdType="pmc">PMC6658703</ArticleId>
            <ArticleId IdType="pubmed">31346203</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nicolas M, Wolfer A, Raj K, Kummer JA, Mill P, van Noort M, Hui CC, Clevers H, Dotto GP, Radtke F. Notch1 functions as a tumor suppressor in mouse skin. Nat Genet. 2003;33(3):416–421. doi: 10.1038/ng1099.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng1099</ArticleId>
            <ArticleId IdType="pubmed">12590261</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang NJ, Sanborn Z, Arnett KL, Bayston LJ, Liao W, Proby CM, Leigh IM, Collisson EA, Gordon PB, Jakkula L, Pennypacker S, Zou Y, Sharma M, North JP, Vemula SS, Mauro TM, Neuhaus IM, Leboit PE, Hur JS, Park K, Huh N, Kwok PY, Arron ST, Massion PP, Bale AE, Haussler D, Cleaver JE, Gray JW, Spellman PT, South AP, Aster JC, Blacklow SC, Cho RJ. Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc Natl Acad Sci U S A. 2011;108(43):17761–17766. doi: 10.1073/pnas.1114669108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1114669108</ArticleId>
            <ArticleId IdType="pmc">PMC3203814</ArticleId>
            <ArticleId IdType="pubmed">22006338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gratton R, Tricarico PM, Moltrasio C, Lima Estevao de Oliveira AS, Brandao L, Marzano AV, Zupin L, Crovella S. Pleiotropic role of Notch signaling in human skin diseases. Int J Mol Sci. 2020 doi: 10.3390/ijms21124214.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms21124214</ArticleId>
            <ArticleId IdType="pmc">PMC7353046</ArticleId>
            <ArticleId IdType="pubmed">32545758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim JE, Lee JH, Jeong KH, Kim GM, Kang H. Notch intracellular domain expression in various skin fibroproliferative diseases. Ann Dermatol. 2014;26(3):332–337. doi: 10.5021/ad.2014.26.3.332.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5021/ad.2014.26.3.332</ArticleId>
            <ArticleId IdType="pmc">PMC4069643</ArticleId>
            <ArticleId IdType="pubmed">24966632</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abdulle AE, Diercks GFH, Feelisch M, Mulder DJ, van Goor H. The role of oxidative stress in the development of systemic sclerosis related vasculopathy. Front Physiol. 2018;9:1177. doi: 10.3389/fphys.2018.01177.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphys.2018.01177</ArticleId>
            <ArticleId IdType="pmc">PMC6117399</ArticleId>
            <ArticleId IdType="pubmed">30197602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krieg T, Takehara K. Skin disease: a cardinal feature of systemic sclerosis. Rheumatology (Oxford) 2009;48(Suppl 3):iii14–iii18. doi: 10.1093/rheumatology/kep108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/rheumatology/kep108</ArticleId>
            <ArticleId IdType="pubmed">19487217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ayers NB, Sun CM, Chen SY. Transforming growth factor-beta signaling in systemic sclerosis. J Biomed Res. 2018;32(1):3–12. doi: 10.7555/JBR.31.20170034.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7555/JBR.31.20170034</ArticleId>
            <ArticleId IdType="pmc">PMC5956255</ArticleId>
            <ArticleId IdType="pubmed">29353817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zmorzynski S, Styk W, Filip AA, Krasowska D. The significance of NOTCH pathway in the development of fibrosis in systemic sclerosis. Ann Dermatol. 2019;31(4):365–371. doi: 10.5021/ad.2019.31.4.365.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5021/ad.2019.31.4.365</ArticleId>
            <ArticleId IdType="pmc">PMC7992759</ArticleId>
            <ArticleId IdType="pubmed">33911613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kavian N, Servettaz A, Mongaret C, Wang A, Nicco C, Chereau C, Grange P, Vuiblet V, Birembaut P, Diebold MD, Weill B, Dupin N, Batteux F. Targeting ADAM-17/notch signaling abrogates the development of systemic sclerosis in a murine model. Arthritis Rheum. 2010;62(11):3477–3487. doi: 10.1002/art.27626.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.27626</ArticleId>
            <ArticleId IdType="pubmed">20583103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Z, Oliver P, Lancaster JR, Jr, Schwarzenberger PO, Joshi MS, Cork J, Kolls JK. Reactive oxygen species mediate tumor necrosis factor alpha-converting, enzyme-dependent ectodomain shedding induced by phorbol myristate acetate. FASEB J. 2001;15(2):303–305. doi: 10.1096/fj.00-0371fje.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1096/fj.00-0371fje</ArticleId>
            <ArticleId IdType="pubmed">11156944</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shao MX, Nadel JA. Dual oxidase 1-dependent MUC5AC mucin expression in cultured human airway epithelial cells. Proc Natl Acad Sci U S A. 2005;102(3):767–772. doi: 10.1073/pnas.0408932102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0408932102</ArticleId>
            <ArticleId IdType="pmc">PMC545521</ArticleId>
            <ArticleId IdType="pubmed">15640347</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654–659. doi: 10.1038/ncb1596.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncb1596</ArticleId>
            <ArticleId IdType="pubmed">17486113</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Colletti M, Galardi A, De Santis M, Guidelli GM, Di Giannatale A, Di Luigi L, Antinozzi C. Exosomes in systemic sclerosis: messengers between immune, vascular and fibrotic components? Int J Mol Sci. 2019 doi: 10.3390/ijms20184337.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms20184337</ArticleId>
            <ArticleId IdType="pmc">PMC6770454</ArticleId>
            <ArticleId IdType="pubmed">31487964</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wermuth PJ, Piera-Velazquez S, Jimenez SA. Exosomes isolated from serum of systemic sclerosis patients display alterations in their content of profibrotic and antifibrotic microRNA and induce a profibrotic phenotype in cultured normal dermal fibroblasts. Clin Exp Rheumatol. 2017;35 Suppl 106(4):21–30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6530475</ArticleId>
            <ArticleId IdType="pubmed">28094758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li L, Zuo X, Liu D, Luo H, Zhu H. The profiles of miRNAs and lncRNAs in peripheral blood neutrophils exosomes of diffuse cutaneous systemic sclerosis. J Dermatol Sci. 2020;98(2):88–97. doi: 10.1016/j.jdermsci.2020.02.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jdermsci.2020.02.009</ArticleId>
            <ArticleId IdType="pubmed">32147195</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iwamoto N, Distler JH, Distler O. Tyrosine kinase inhibitors in the treatment of systemic sclerosis: from animal models to clinical trials. Curr Rheumatol Rep. 2011;13(1):21–27. doi: 10.1007/s11926-010-0142-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11926-010-0142-x</ArticleId>
            <ArticleId IdType="pubmed">21042889</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fraticelli P, Gabrielli B, Pomponio G, Valentini G, Bosello S, Riboldi P, Gerosa M, Faggioli P, Giacomelli R, Del Papa N, Gerli R, Lunardi C, Bombardieri S, Malorni W, Corvetta A, Moroncini G, Gabrielli A, Imatinib in Scleroderma Italian Study G  Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study. Arthritis Res Ther. 2014;16(4):144. doi: 10.1186/ar4606.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/ar4606</ArticleId>
            <ArticleId IdType="pmc">PMC4227120</ArticleId>
            <ArticleId IdType="pubmed">25007944</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harrach S, Barz V, Pap T, Pavenstadt H, Schlatter E, Edemir B, Distler J, Ciarimboli G, Bertrand J. Notch signaling activity determines uptake and biological effect of imatinib in systemic sclerosis dermal fibroblasts. J Invest Dermatol. 2019;139(2):439–447. doi: 10.1016/j.jid.2018.08.021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jid.2018.08.021</ArticleId>
            <ArticleId IdType="pubmed">30273596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zmorzynski S, Wojcierowska-Litwin M, Kowal M, Michalska-Jakubus M, Styk W, Filip AA, Walecka I, Krasowska D. NOTCH3 T6746C and TP53 P72R polymorphisms are associated with the susceptibility to diffuse cutaneous systemic sclerosis. Biomed Res Int. 2020;2020:8465971. doi: 10.1155/2020/8465971.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2020/8465971</ArticleId>
            <ArticleId IdType="pmc">PMC7060860</ArticleId>
            <ArticleId IdType="pubmed">32185220</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berman B, Maderal A, Raphael B. Keloids and hypertrophic scars: pathophysiology, classification, and treatment. Dermatol Surg. 2017;43(Suppl 1):S3–S18. doi: 10.1097/DSS.0000000000000819.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/DSS.0000000000000819</ArticleId>
            <ArticleId IdType="pubmed">27347634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Limandjaja GC, Belien JM, Scheper RJ, Niessen FB, Gibbs S. Hypertrophic and keloid scars fail to progress from the CD34(−) /alpha-smooth muscle actin (alpha-SMA)(+) immature scar phenotype and show gradient differences in alpha-SMA and p16 expression. Br J Dermatol. 2020;182(4):974–986. doi: 10.1111/bjd.18219.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bjd.18219</ArticleId>
            <ArticleId IdType="pubmed">31206605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Machesney M, Tidman N, Waseem A, Kirby L, Leigh I. Activated keratinocytes in the epidermis of hypertrophic scars. Am J Pathol. 1998;152(5):1133–1141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1858601</ArticleId>
            <ArticleId IdType="pubmed">9588880</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li B, Gao C, Diao JS, Wang DL, Chu FF, Li Y, Wang G, Guo SZ, Xia W. Aberrant Notch signalling contributes to hypertrophic scar formation by modulating the phenotype of keratinocytes. Exp Dermatol. 2016;25(2):137–142. doi: 10.1111/exd.12897.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/exd.12897</ArticleId>
            <ArticleId IdType="pubmed">26566963</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao J, Yu J, Xu Y, Chen L, Zhou F, Zhai Q, Wu J, Shu B, Qi S. Epidermal HMGB1 activates dermal fibroblasts and causes hypertrophic scar formation in reduced hydration. J Invest Dermatol. 2018;138(11):2322–2332. doi: 10.1016/j.jid.2018.04.036.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jid.2018.04.036</ArticleId>
            <ArticleId IdType="pubmed">29787749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feng Y, Sun ZL, Liu SY, Wu JJ, Zhao BH, Lv GZ, Du Y, Yu S, Yang ML, Yuan FL, Zhou XJ. Direct and indirect roles of macrophages in hypertrophic scar formation. Front Physiol. 2019;10:1101. doi: 10.3389/fphys.2019.01101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphys.2019.01101</ArticleId>
            <ArticleId IdType="pmc">PMC6724447</ArticleId>
            <ArticleId IdType="pubmed">31555142</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He T, Bai X, Jing J, Liu Y, Wang H, Zhang W, Li X, Li Y, Wang L, Xie S, Hu D. Notch signal deficiency alleviates hypertrophic scar formation after wound healing through the inhibition of inflammation. Arch Biochem Biophys. 2020;682:108286. doi: 10.1016/j.abb.2020.108286.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.abb.2020.108286</ArticleId>
            <ArticleId IdType="pubmed">32007475</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Han B, Fan J, Liu L, Tian J, Gan C, Yang Z, Jiao H, Zhang T, Liu Z, Zhang H. Adipose-derived mesenchymal stem cells treatments for fibroblasts of fibrotic scar via downregulating TGF-beta1 and Notch-1 expression enhanced by photobiomodulation therapy. Lasers Med Sci. 2019;34(1):1–10. doi: 10.1007/s10103-018-2567-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10103-018-2567-9</ArticleId>
            <ArticleId IdType="pubmed">30367294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andrews JP, Marttala J, Macarak E, Rosenbloom J, Uitto J. Keloids: the paradigm of skin fibrosis—pathomechanisms and treatment. Matrix Biol. 2016;51:37–46. doi: 10.1016/j.matbio.2016.01.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.matbio.2016.01.013</ArticleId>
            <ArticleId IdType="pmc">PMC4842154</ArticleId>
            <ArticleId IdType="pubmed">26844756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Syed F, Bayat A. Notch signaling pathway in keloid disease: enhanced fibroblast activity in a Jagged-1 peptide-dependent manner in lesional vs extralesional fibroblasts. Wound Repair Regen. 2012;20(5):688–706. doi: 10.1111/j.1524-475X.2012.00823.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1524-475X.2012.00823.x</ArticleId>
            <ArticleId IdType="pubmed">22985040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee S, Kim SK, Park H, Lee YJ, Park SH, Lee KJ, Lee DG, Kang H, Kim JE. Contribution of autophagy-Notch1-mediated NLRP3 inflammasome activation to chronic inflammation and fibrosis in keloid fibroblasts. Int J Mol Sci. 2020 doi: 10.3390/ijms21218050.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms21218050</ArticleId>
            <ArticleId IdType="pmc">PMC7663397</ArticleId>
            <ArticleId IdType="pubmed">33126764</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Onoufriadis A, Hsu CK, Ainali C, Ung CY, Rashidghamat E, Yang HS, Huang HY, Niazi U, Tziotzios C, Yang JC, Nuamah R, Tang MJ, Saxena A, de Rinaldis E, McGrath JA. Time series integrative analysis of RNA sequencing and microRNA expression data reveals key biologic wound healing pathways in keloid-prone individuals. J Invest Dermatol. 2018;138(12):2690–2693. doi: 10.1016/j.jid.2018.05.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jid.2018.05.017</ArticleId>
            <ArticleId IdType="pubmed">29870686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Has C, Bauer JW, Bodemer C, Bolling MC, Bruckner-Tuderman L, Diem A, Fine JD, Heagerty A, Hovnanian A, Marinkovich MP, Martinez AE, McGrath JA, Moss C, Murrell DF, Palisson F, Schwieger-Briel A, Sprecher E, Tamai K, Uitto J, Woodley DT, Zambruno G, Mellerio JE. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. Br J Dermatol. 2020;183(4):614–627. doi: 10.1111/bjd.18921.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bjd.18921</ArticleId>
            <ArticleId IdType="pubmed">32017015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Odorisio T, Di Salvio M, Orecchia A, Di Zenzo G, Piccinni E, Cianfarani F, Travaglione A, Uva P, Bellei B, Conti A, Zambruno G, Castiglia D. Monozygotic twins discordant for recessive dystrophic epidermolysis bullosa phenotype highlight the role of TGF-beta signalling in modifying disease severity. Hum Mol Genet. 2014;23(15):3907–3922. doi: 10.1093/hmg/ddu102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddu102</ArticleId>
            <ArticleId IdType="pubmed">24599399</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guerra L, Odorisio T, Zambruno G, Castiglia D. Stromal microenvironment in type VII collagen-deficient skin: the ground for squamous cell carcinoma development. Matrix Biol. 2017;63:1–10. doi: 10.1016/j.matbio.2017.01.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.matbio.2017.01.002</ArticleId>
            <ArticleId IdType="pubmed">28126522</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Condorelli AG, Dellambra E, Logli E, Zambruno G, Castiglia D. Epidermolysis bullosa-associated squamous cell carcinoma: from pathogenesis to therapeutic perspectives. Int J Mol Sci. 2019 doi: 10.3390/ijms20225707.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms20225707</ArticleId>
            <ArticleId IdType="pmc">PMC6888002</ArticleId>
            <ArticleId IdType="pubmed">31739489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cho RJ, Alexandrov LB, den Breems NY, Atanasova VS, Farshchian M, Purdom E, Nguyen TN, Coarfa C, Rajapakshe K, Prisco M, Sahu J, Tassone P, Greenawalt EJ, Collisson EA, Wu W, Yao H, Su X, Guttmann-Gruber C, Hofbauer JP, Hashmi R, Fuentes I, Benz SC, Golovato J, Ehli EA, Davis CM, Davies GE, Covington KR, Murrell DF, Salas-Alanis JC, Palisson F, Bruckner AL, Robinson W, Has C, Bruckner-Tuderman L, Titeux M, Jonkman MF, Rashidghamat E, Lwin SM, Mellerio JE, McGrath JA, Bauer JW, Hovnanian A, Tsai KY, South AP. APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa. Sci Transl Med. 2018 doi: 10.1126/scitranslmed.aas9668.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/scitranslmed.aas9668</ArticleId>
            <ArticleId IdType="pubmed">30135250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Massi D, Tarantini F, Franchi A, Paglierani M, Di Serio C, Pellerito S, Leoncini G, Cirino G, Geppetti P, Santucci M. Evidence for differential expression of Notch receptors and their ligands in melanocytic nevi and cutaneous malignant melanoma. Mod Pathol. 2006;19(2):246–254. doi: 10.1038/modpathol.3800526.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/modpathol.3800526</ArticleId>
            <ArticleId IdType="pubmed">16341148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kolev V, Mandinova A, Guinea-Viniegra J, Hu B, Lefort K, Lambertini C, Neel V, Dummer R, Wagner EF, Dotto GP. EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer. Nat Cell Biol. 2008;10(8):902–911. doi: 10.1038/ncb1750.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncb1750</ArticleId>
            <ArticleId IdType="pmc">PMC2747621</ArticleId>
            <ArticleId IdType="pubmed">18604200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Al Labban D, Jo SH, Ostano P, Saglietti C, Bongiovanni M, Panizzon R, Dotto GP. Notch-effector CSL promotes squamous cell carcinoma by repressing histone demethylase KDM6B. J Clin Invest. 2018;128(6):2581–2599. doi: 10.1172/JCI96915.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI96915</ArticleId>
            <ArticleId IdType="pmc">PMC5983322</ArticleId>
            <ArticleId IdType="pubmed">29757189</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andersson ER, Lendahl U. Therapeutic modulation of Notch signalling—are we there yet? Nat Rev Drug Discov. 2014;13(5):357–378. doi: 10.1038/nrd4252.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrd4252</ArticleId>
            <ArticleId IdType="pubmed">24781550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yuan X, Wu H, Xu H, Xiong H, Chu Q, Yu S, Wu GS, Wu K. Notch signaling: an emerging therapeutic target for cancer treatment. Cancer Lett. 2015;369(1):20–27. doi: 10.1016/j.canlet.2015.07.048.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.canlet.2015.07.048</ArticleId>
            <ArticleId IdType="pubmed">26341688</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Katoh M, Katoh M. Precision medicine for human cancers with Notch signaling dysregulation (Review) Int J Mol Med. 2020;45(2):279–297. doi: 10.3892/ijmm.2019.4418.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/ijmm.2019.4418</ArticleId>
            <ArticleId IdType="pmc">PMC6984804</ArticleId>
            <ArticleId IdType="pubmed">31894255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moore G, Annett S, McClements L, Robson T. Top Notch targeting strategies in cancer: a detailed overview of recent insights and current perspectives. Cells. 2020 doi: 10.3390/cells9061503.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cells9061503</ArticleId>
            <ArticleId IdType="pmc">PMC7349363</ArticleId>
            <ArticleId IdType="pubmed">32575680</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Kloe GE, De Strooper B. Small molecules that inhibit Notch signaling. Methods Mol Biol. 2014;1187:311–322. doi: 10.1007/978-1-4939-1139-4_23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-1-4939-1139-4_23</ArticleId>
            <ArticleId IdType="pubmed">25053499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ntziachristos P, Lim JS, Sage J, Aifantis I. From fly wings to targeted cancer therapies: a centennial for notch signaling. Cancer Cell. 2014;25(3):318–334. doi: 10.1016/j.ccr.2014.02.018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccr.2014.02.018</ArticleId>
            <ArticleId IdType="pmc">PMC4040351</ArticleId>
            <ArticleId IdType="pubmed">24651013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ran Y, Hossain F, Pannuti A, Lessard CB, Ladd GZ, Jung JI, Minter LM, Osborne BA, Miele L, Golde TE. gamma-Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct. EMBO Mol Med. 2017;9(7):950–966. doi: 10.15252/emmm.201607265.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.15252/emmm.201607265</ArticleId>
            <ArticleId IdType="pmc">PMC5494507</ArticleId>
            <ArticleId IdType="pubmed">28539479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Massard C, Azaro A, Soria JC, Lassen U, Le Tourneau C, Sarker D, Smith C, Ohnmacht U, Oakley G, Patel BKR, Yuen ESM, Benhadji KA, Rodon J. First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer. Ann Oncol. 2018;29(9):1911–1917. doi: 10.1093/annonc/mdy244.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/annonc/mdy244</ArticleId>
            <ArticleId IdType="pubmed">30060061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hyde LA, McHugh NA, Chen J, Zhang Q, Manfra D, Nomeir AA, Josien H, Bara T, Clader JW, Zhang L, Parker EM, Higgins GA. Studies to investigate the in vivo therapeutic window of the gamma-secretase inhibitor N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-di hydro-5H-dibenzo[b, d]azepin-7-yl]-L-alaninamide (LY411,575) in the CRND8 mouse. J Pharmacol Exp Ther. 2006;319(3):1133–1143. doi: 10.1124/jpet.106.111716.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1124/jpet.106.111716</ArticleId>
            <ArticleId IdType="pubmed">16946102</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Distler A, Lang V, Del Vecchio T, Huang J, Zhang Y, Beyer C, Lin NY, Palumbo-Zerr K, Distler O, Schett G, Distler JH. Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability. Ann Rheum Dis. 2014;73(6):1264–1268. doi: 10.1136/annrheumdis-2013-204221.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/annrheumdis-2013-204221</ArticleId>
            <ArticleId IdType="pubmed">24445254</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moellering RE, Cornejo M, Davis TN, Del Bianco C, Aster JC, Blacklow SC, Kung AL, Gilliland DG, Verdine GL, Bradner JE. Direct inhibition of the NOTCH transcription factor complex. Nature. 2009;462(7270):182–188. doi: 10.1038/nature08543.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature08543</ArticleId>
            <ArticleId IdType="pmc">PMC2951323</ArticleId>
            <ArticleId IdType="pubmed">19907488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu Y, Cain-Hom C, Choy L, Hagenbeek TJ, de Leon GP, Chen Y, Finkle D, Venook R, Wu X, Ridgway J, Schahin-Reed D, Dow GJ, Shelton A, Stawicki S, Watts RJ, Zhang J, Choy R, Howard P, Kadyk L, Yan M, Zha J, Callahan CA, Hymowitz SG, Siebel CW. Therapeutic antibody targeting of individual Notch receptors. Nature. 2010;464(7291):1052–1057. doi: 10.1038/nature08878.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature08878</ArticleId>
            <ArticleId IdType="pubmed">20393564</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Astudillo L, Da Silva TG, Wang Z, Han X, Jin K, VanWye J, Zhu X, Weaver K, Oashi T, Lopes PE, Orton D, Neitzel LR, Lee E, Landgraf R, Robbins DJ, MacKerell AD, Jr, Capobianco AJ. The small molecule IMR-1 inhibits the Notch transcriptional activation complex to suppress tumorigenesis. Cancer Res. 2016;76(12):3593–3603. doi: 10.1158/0008-5472.CAN-16-0061.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-16-0061</ArticleId>
            <ArticleId IdType="pmc">PMC4911243</ArticleId>
            <ArticleId IdType="pubmed">27197169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gomez-Galeno JE, Hurtado C, Cheng J, Yardimci C, Mercola M, Cashman JR. b-Annulated 1,4-dihydropyridines as Notch inhibitors. Bioorg Med Chem Lett. 2018;28(20):3363–3367. doi: 10.1016/j.bmcl.2018.09.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bmcl.2018.09.002</ArticleId>
            <ArticleId IdType="pmc">PMC6261437</ArticleId>
            <ArticleId IdType="pubmed">30201292</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hurtado C, Safarova A, Smith M, Chung R, Bruyneel AAN, Gomez-Galeno J, Oswald F, Larson CJ, Cashman JR, Ruiz-Lozano P, Janiak P, Suzuki T, Mercola M. Disruption of NOTCH signaling by a small molecule inhibitor of the transcription factor RBPJ. Sci Rep. 2019;9(1):10811. doi: 10.1038/s41598-019-46948-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-019-46948-5</ArticleId>
            <ArticleId IdType="pmc">PMC6658660</ArticleId>
            <ArticleId IdType="pubmed">31346210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Masiero M, Li D, Whiteman P, Bentley C, Greig J, Hassanali T, Watts S, Stribbling S, Yates J, Bealing E, Li JL, Chillakuri C, Sheppard D, Serres S, Sarmiento-Soto M, Larkin J, Sibson NR, Handford PA, Harris AL, Banham AH. Development of therapeutic anti-JAGGED1 antibodies for cancer therapy. Mol Cancer Ther. 2019;18(11):2030–2042. doi: 10.1158/1535-7163.MCT-18-1176.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1535-7163.MCT-18-1176</ArticleId>
            <ArticleId IdType="pubmed">31395687</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou Y, Liao S, Zhang Z, Wang B, Wan L. Astragalus injection attenuates bleomycin-induced pulmonary fibrosis via down-regulating Jagged1/Notch1 in lungs. J Pharm Pharmacol. 2016;68(3):389–396. doi: 10.1111/jphp.12518.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jphp.12518</ArticleId>
            <ArticleId IdType="pubmed">26817817</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
